| Excerpt | Reference |
|---|
| "As a rule bacterial infection is followed by acute serum iron reduction; impaired inflow of iron from storage sites into the transport pool represents the main cause." | ( Ganzoni, AM; Puschmann, M, 1978) |
| "Bacterial infections are usually easily treated, although they frequently disseminate and often recur after seemingly appropriate treatment." | ( Daar, ES; Meyer, RD, 1992) |
| "In particular bacterial infection is important only in the pathogenesis of brown PSs while it plays no role in the initial formation of cholesterol, mixed or black GSs." | ( Cetta, F, 1991) |
| "Bacterial infection is a common complication after allogeneic bone marrow transplantation." | ( Arlet, C; Bourdeau, H; Devergie, A; Gluckman, E; Hirsch, I; Perol, Y; Roudet, C, 1991) |
| "The incidence of bacterial infection are higher in the pigmented calcium stone than cholesterol stone." | ( Fu, HQ, 1989) |
| "The secondary bacterial infection is usually caused by Haemophilus influenzae, Streptococcus pneumoniae and anaerobic bacteria." | ( Ekedahl, C, 1987) |
| "Bacterial infections are frequent events in premature and newborn infants." | ( Guggenbichler, JP, 1983) |
| "Although bacterial infection is very common in patients with adult respiratory distress syndrome (ARDS), the effects of infection on the clinical course of ARDS are unknown." | ( Campbell, GD; Coalson, JJ; Johanson, WG, 1984) |
| "Jaundice of severe bacterial infection is well known." | ( Dobbins, WO; Fang, MH; Ginsberg, AL, 1980) |
| "To determine whether bacterial infection is an important component in the pathogenesis of an exacerbation, the effects of antimicrobial treatment must be studied." | ( Groenier, KH; Koëter, GH; Meyboom-de Jong, B; Sachs, AP; Schiphuis, J; van der Waaij, D, 1995) |
| "Serious bacterial infections are common in children infected with the human immunodeficiency virus (HIV)." | ( Abrams, E; Barzilai, A; Bryson, YJ; Connor, EM; Dankner, WM; Gelber, RD; Livingston, RA; McGrath, N; Spector, SA; Wara, D, 1994) |
| "Neonatal bacterial infections are potentially lethal." | ( Bérard, E; Boutté, P; Chanalet, L; Dageville, C; Garraffo, R; Mariani, R, 1994) |
| "Bacterial infection is a major cause of morbidity and mortality in neutropenic patients." | ( Benn, R; Gibson, J; Iland, H; Johnson, L; Joshua, D; Kronenberg, H; MacLeod, C; Snowdon, L; Vincent, P; Young, G, 1994) |
| "Bacterial diseases are frequent in captivity." | ( Gerlach, H; Kösters, J; Schales, C, 1993) |
| "Major bacterial infections are most commonly associated with agranulocytosis or an abnormality of immunoglobulins or complement." | ( Bogomolski-Yahalom, V; Matzner, Y, 1995) |
| "Bacterial infections are more frequently found in semen samples from asymptomatic infertile patients than in those from fertile men." | ( el Mulla, KF; Erdmann, I; Köhn, FM; Oeda, T; Schiefer, HG; Schill, WB, 1998) |
| "Bacterial infection is a significant cause of morbidity and mortality in hemodialysis patients, and a number of studies have implicated iron overload as a risk factor for bacterial infection in these patients." | ( Hoen, B, 1999) |
| "Bacterial infection is a major cause of neonatal morbidity and mortality." | ( Berner, R; Brandis, M; Clad, A; Forster, J; Tüxen, B, 2000) |
| "The therapy of bacterial infections is currently a difficult problem of the contemporary medicine, mainly due to the increasing spread of resistance to conventional antibiotics and to the appearance of multi-resistant bacterial strains." | ( Igaz, P, 2001) |
| "Certain bacterial infections are commoner (e." | ( Brandt, LJ; Slotwiner-Nie, PK, 2001) |
| "Concurrent serious bacterial infections are rare in infants and children hospitalized with RSV lower respiratory tract infections and the empiric use of broad-spectrum intravenous antibiotics is unnecessary in children with typical signs and symptoms of RSV bronchiolitis." | ( Fergie, J; Purcell, K, 2002) |
| "To assess if bacterial infection is associated with endogenous heparinoids in cirrhotics, thus impairing coagulation." | ( Burroughs, AK; Cox, DJ; Montalto, P; Pastacaldi, S; Patch, D; Vlachogiannakos, J, 2002) |
| "Bacterial infections are life-threatening complications in cirrhosis and early diagnosis is mandatory." | ( Connert, S; Elsing, C; Stremmel, W, 2003) |
| "The risk of severe bacterial infection is also high in sickle-cell anemia children and is the leading cause of death in this age group." | ( de Montalembert, M, 2003) |
| "Bacterial infections are also the main cause of death in oncological patients." | ( Bivona, G; Ciaccio, M; Di Gangi, M; Fugardi, G; Giordano, S; Romano, A; Scarlata, F; Titone, L; Vocca, L, 2004) |
| "Bacterial infections are associated with a high morbidity and mortality rate in patients with acute and chronic renal failure." | ( Bölke, E; Grünert, A; Orth, K; Steinbach, G; Störck, M, 2004) |
| "Bacterial infection is implicated in the selective CNS white matter injury associated with cerebral palsy, a common birth disorder." | ( Fern, R; Sherwin, C, 2005) |
| "Bacterial infections are a major cause of morbidity and mortality in neutropenic patients following chemotherapy for malignancy." | ( Fraser, A; Gafter-Gvili, A; Kremer, L; Leibovici, L; Paul, M; van de Wetering, M, 2005) |
| "Bacterial infections are major life-threatening complications in patients receiving cytotoxic drugs." | ( Heo, SK; Kim, BS; Kim, H; Kim, MJ; Lee, EH; Min, YJ; Park, JH; Park, SK, 2006) |
| "However, bacterial infections are important causes of high fever in patients receiving myelosuppressive chemotherapy, and such fevers persist despite the use of COX inhibitors." | ( Dascombe, MJ; Maldonado, R; Miñano, FJ; Tavares, E, 2006) |
| "Bacterial infections are well described complications of cirrhosis that greatly increase mortality rates." | ( Farkas, A; Papp, M; Tornai, I; Udvardy, M, 2007) |
| "Identification of bacterial infections is crucial if treatment is to be initiated early and antibiotics used rationally." | ( Bernard, M; Haroche, J; Hausfater, P; Juillien, G; Madonna-Py, B; Riou, B, 2007) |
| "Bacterial infection is a major cause of morbidity and mortality among patients with HIV living in Africa." | ( Spencer, DC, 2007) |
| "The likelihood of bacterial infection is low among COPD patients admitted to ICU for AECOPD (40% with PCT < 0." | ( Charbonneau, P; Daubin, C; du Cheyron, D; Fradin, S; Freymuth, F; Parienti, JJ; Ramakers, M; Terzi, N; Vabret, A, 2008) |
| "Bacterial infections are the most frequent cause of hospitalization in elderly patients." | ( Acone, N; Carpentieri, MS; Cellesi, C; Cellini, A; De Lalla, F; Esposito, S; Foti, G; Ghinelli, F; Girmenia, C; Ianniello, F; Leone, S; Maiello, A; Maio, P; Marranconi, F; Noviello, S; Pantaleoni, M; Re, T; Russo, M; Sabbatani, S; Scudeller, L; Soranzo, ML; Viale, P; Viganò, P; Zanelli, G, 2009) |
| "However, an acute bacterial infection is rarely reported as the first manifestation of underlying MM." | ( Christou, L; Kalambokis, GN; Tsianos, EV, 2009) |
| "Bacterial infection is known to trigger a number of autoimmune disorders, an observation that indicates a potentially important role for antibiotics in treating these diseases." | ( Ebringer, A, 2010) |
| "Bacterial infections are a frequent secondary problem." | ( McKay, L; Pieper, J, 2011) |
| "Bacterial infections are common cause of morbidity and mortality in patients with cirrhosis." | ( Altorjay, I; Antal-Szalmas, P; Harsfalvi, J; Kappelmayer, J; Lakatos, PL; Papp, M; Tornai, I; Udvardy, M; Vida, A; Vitalis, Z, 2012) |
| "Abstract." | ( Alborzi, A; Pasyar, N; Pouladfar, GR, 2012) |
| "Bacterial infections are a major cause of morbidity and mortality in patients who are neutropenic following chemotherapy for malignancy." | ( Fraser, A; Gafter-Gvili, A; Kremer, LC; Lawrie, TA; Leibovici, L; Paul, M; van de Wetering, MD; Vidal, L, 2012) |
| "Secondary bacterial infections are common." | ( Bettenay, S; Kuznetsova, E; Majzoub, M; Mueller, R; Nikolaeva, L, 2012) |
| "Serious bacterial infections are a major cause of death in early infancy in developing countries." | ( Aneja, S; Bhatnagar, S; Chandra, J; Dutta, AK; Kabra, SK; Kumari, M; Lodha, R; Natchu, UC; Rath, B; Sharma, M; Sharma, VK; Sommerfelt, H; Strand, TA; Wadhwa, N, 2012) |
| "Implant-associated bacterial infections are one of the most serious complications in orthopedic surgery." | ( Carpenter, D; Hsu, C; Lee, KS; Liu, Y; Miller, LS; Siu, RK; Soo, C; Soofer, DE; Ting, K; Wang, C; Zara, JN; Zhang, X; Zheng, Z, 2012) |
| "Up to 80% of human bacterial infections are biofilm associated; such infections are most frequently caused by Staphylococcus epidermidis, Pseudomonas aeruginosa, Staphylococcus aureus and Enterobacteria such as Escherichia coli." | ( Balsalobre, C; Römling, U, 2012) |
| "Bacterial infections are a major cause of acute exacerbations of both conditions which have a major impact on healthcare resources, quality of life and disease progression." | ( Macklin-Doherty, A; Wilson, R, 2012) |
| "Early recognition of bacterial infections is crucial for their proper management, but is particularly difficult in children with severe acute malnutrition (SAM)." | ( Aberrane, S; Baron, E; de Rekeneire, N; Dehoux, M; Janssens, AC; Page, AL; Sayadi, S, 2014) |
| "Bacterial infections are common in cirrhotic patients with acute variceal bleeding, occurring in 20% within 48 h." | ( Lee, YY; Mahadeva, S; Tee, HP, 2014) |
| "The treatment of bacterial infection is one of the most challenging tasks in the biomedical field." | ( Li, LL; Qi, GB; Wang, H; Xu, JH; Yu, F; Zhao, X, 2014) |
| "Bacterial infections are major causes of early morbidity and mortality after liver transplantation." | ( Bazerbachi, F; Cattral, M; Ghanekar, A; Grant, D; Humar, A; Husain, S; Katchman, E; Low, CY; Marquez, M; Renner, E; Rotstein, C; Selzner, M, 2014) |
| "Bacterial infections are a leading cause of morbidity and mortality among solid organ transplant recipients." | ( de Gouvêa, EF; Santoro-Lopes, G, 2014) |
| "Viral and bacterial infections are often associated with deficiencies in macronutrients and micronutrients, including the essential trace element selenium." | ( Al-Quraishy, S; Dkhil, MA; Sies, H; Steinbrenner, H; Wunderlich, F, 2015) |
| "Bacterial infection is an important cause of death in patients with liver cirrhosis." | ( Jang, JW; Kim, DG; Kim, IH; Kim, SH; Kim, SM; Kim, SW; Lee, CH; Lee, SO; Lee, ST; Park, JK, 2015) |
| "Rapid diagnosis of bacterial infections is crucial for adequate antibiotic treatment." | ( Angeletti, S; Cavalieri, D; Cortigiani, M; Costantino, S; Curcio, B; De Florio, L; Dicuonzo, G; Fioravanti, M; Fogolari, M; Spoto, S, 2015) |
| "Bacterial infections are quite frequent among the elderly, and use of antimicrobials may be associated with severe adverse events in this population, especially when in presence of co-medications and/or of co-morbidities." | ( Pea, F, 2015) |
| "Bacterial infection is one of the major causes of death in patients with thalassemia." | ( Chansung, K; Jetsrisuparb, A; Sirijerachai, C; Teawtrakul, N; Wanitpongpun, C, 2015) |
| "Bacterial infections are a serious complication of cirrhosis, as they can lead to decompensation, multiple organ failure, and/or death." | ( Garcia-Tsao, G; Yan, K, 2016) |
| "Bacterial infections are a common clinical problem in both acute and chronic wounds." | ( Becerra, SC; Burmeister, DM; Christy, RJ; Roy, DC; Sanchez, CJ, 2016) |
| "The treatment of bacterial infections is challenging because of a decline in the current arsenal of useful antibiotics and the slow rate of new drug development." | ( Devereux, M; Howe, O; McCann, M; McCarron, P; Viganor, L, 2017) |
| "Bacterial infections are the second leading cause of global mortality." | ( de Marco, BA; Fanelli, S; Natori, JSH; Salgado, HRN; Tótoli, EG, 2017) |
| "Bacterial infections are a major concern in the human health sector due to poor diagnosis and development of multidrug-resistant strains." | ( Albericio, F; Baijnath, S; Chuturgoon, A; de la Torre, BG; Dutta, J; Ebenhan, T; Govender, T; Kruger, HG; Marjanovic-Painter, B; Nagiah, S; Naicker, T; Sathekge, M; Somboro, AM; Zeevaart, JR, 2017) |
| "Bacterial infections are a leading factor in the progression from compensated to decompensated cirrhosis, with consequent worsening of the prognosis, and concerted efforts have been made to reduce infections and improve the survival rate of these patients." | ( Bruno, R; Columpsi, P; Filice, G; Lombardi, A; Mariani, M; Marone, P; Patruno, SF; Sacchi, P; Scudeller, L; Vecchia, M; Zuccaro, V, 2017) |
| "Bacterial infections are serious health threats." | ( Ahmed, MS; Annamalai, T; Li, X; Moon, JH; Seddek, A; Teng, P; Tse-Dinh, YC, 2018) |
| "Severe bacterial infections are a leading cause of death among neonates in low-income countries, which harbor several factors leading to emergence and spread of multidrug-resistant bacteria." | ( Collard, JM; Delarocque-Astagneau, E; Feno, H; Garin, B; Goyet, S; Guillemot, D; Hariniaina-Ratsima, E; Herindrainy, P; Huynh, BT; Kermorvant-Duchemin, E; Ndir, A; Padget, M; Piola, P; Raheliarivao, T; Rakotoarimanana, FMJ; Randrianirina, F, 2018) |
| "Bacterial infection is present in up to 30% of hospitalized cirrhotic patients." | ( Almeida, JRS; Correa, BR; Cunha-Silva, M; Imbrizi, MR; Lopes-Secundo, TM; Sevá-Pereira, T; Silva, NCM; Soares, EC, 2018) |
| "Bacterial infection is becoming the biggest threat to human health." | ( An, Y; Li, Y; Liu, Y; Shi, L; Su, L, 2019) |
| "Bacterial infections are the most common cause of purulent soft tissue inflammations in the head and neck area." | ( Bogacz, M; Bubiłek-Bogacz, A; Janowska-Bogacz, K; Mertas, A; Morawiec, T; Pinocy, K; Rój, R; Śmieszek-Wilczewska, J, 2019) |
| "Severe bacterial infections are the first cause of morbidity in people with human immunodeficiency virus (PWH)." | ( Abgrall, S; Carrieri, P; Costagliola, D; Duval, X; Duvivier, C; Enel, P; Freire-Maresca, A; Gallien, S; Guiguet, M; Mary-Krause, M; Melliez, H; Pavie, J; Siguier, M; Tattevin, P, 2020) |
| "Pathogenic bacterial infections are a significant threat to human safety and health." | ( Cui, F; Ping, J; Sun, X; Ye, Y, 2020) |
| "Bacterial infections are responsible for a large number of deaths every year worldwide." | ( Ngugi, MP; Omwenga, GI; Samoei, JC; Sieberi, BM; Wambua, RK, 2020) |
| "The bacterial infection is one of the most common but critical problems in the wound healing process due to the general antibiotic resistance of bacteria." | ( Bai, F; Guo, Z; Li, F; Liu, Y; Wang, L; Zhang, H; Zhang, Y, 2020) |
| "Bacterial infections are the main infectious diseases and cause of death worldwide." | ( Wu, ZL; Xu, R; Zhao, J, 2020) |
| "Bacterial infections are a significant cause of sickness and death in sub-Saharan Africa." | ( Adukwu, EC; Chisale, MRO; Kamudumuli, PS; Kumwenda, P; Ngwira, M; Tabe, ES; Ujor, VC; Wu, JTS, 2021) |
| "Bacterial diseases are a major constraint to this sector and associated with misuse of antibiotics, pose serious threats to public health." | ( Enes, P; Jerusik, R; Oliva-Teles, A; Pousão-Ferreira, P; Saavedra, MJ; Santos, RA; Serra, CR, 2021) |
| "Neonatal bacterial infections are a common cause of death, which can be managed well with inpatient treatment." | ( Aboubaker, S; Abraham, L; Bahl, R; Bayray, A; Fantaye, M; Godefay, H; Hailu, T; Leul, A; Mulugeta, A; Nisar, YB; Qazi, SA; Tekle, E; Terefe, W, 2021) |
| "Secondary bacterial infection is considered as a major complication associated with severe Influenza-A (H1N1)pdm09 infection responsible for the mortalities and morbidities worldwide." | ( Alsultan, M; Ishaqui, AA; Khan, AH; Khan, I; Syed Sulaiman, SA, 2020) |
| "Respiratory bacterial infections are the most frequent and occur early after admission." | ( Abraldes, JG; Albillos, A; Alvarado, E; Amitrano, L; Bañares, R; Bosch, J; Bureau, C; Calleja, JL; Cañete, N; Casas, M; Castellote, J; Catalina, MV; Conejo, I; Dell'Era, A; Ferlitsch, A; Fischer, P; García-Pagán, JC; Genescà, J; Giráldez, Á; Gluud, LL; Gronbaek, H; Guardascione, MA; Hernández-Gea, V; Hernández-Guerra, M; Ibañez-Samaniego, L; Jansen, C; Krag, A; Laleman, W; Llop, E; Martínez, J; Masnou, H; Mundi, JL; Nevens, F; Noronha-Ferreira, C; Palazon, JM; Perez-Campuzano, V; Primignani, M; Procopet, B; Robic, MA; Rodrigues, S; Rodríguez, M; Rodríguez-de-Santiago, E; Romero-Gomez, M; Rudler, M; Sassatelli, R; Schwarzer, R; Senzolo, M; Silva-Junior, G; Téllez, L; Thabut, D; Trebicka, J; Villanueva, C; Zipprich, A, 2021) |
| "Intracellular bacterial infection is underlying many serious human disorders, leading to high morbidity and mortality." | ( Chen, N; Liu, S; Luo, M; Tang, Z; Wu, J; Zheng, Y, 2021) |
| "Bacterial infection is one of the most significant public health challenges due to the limited choices of antibiotics which can overcome antibiotic-resistant bacteria." | ( Dai, X; Gao, F; Ma, J; Xu, Q; Yang, L; Zhang, Q, 2021) |
| "Treatment of bacterial infections is challenging, mainly attributed to the rapidly evolving resistance mechanisms, creating an urgent demand to develop novel antibacterial agents." | ( Hu, G; Jiang, D; Liu, B, 2022) |
| "Bacterial infections are one of the most serious health risks worldwide, and their rapid diagnosis remains a major challenge in clinic." | ( Akakuru, OU; Li, Z; Pan, C; Wu, A; Xu, C; Zheng, J; Zou, R, 2021) |
| "Two-thirds of bacterial infections are associated with biofilms." | ( Cui, F; Li, J; Li, T; Li, X; Wang, D; Yi, S, 2022) |
| "Bacterial infections are very common in NHL patients." | ( Guan, X; He, H; Li, F; Li, H; Li, Z; Ling, X; Shi, K; Yang, T; Yang, Z; Zhang, J; Zhang, L; Zhao, J; Zhao, R; Zhao, S, 2022) |
| "Focal bacterial infections are often difficult to treat due to the rapid emergence of antibiotic-resistant bacteria, high risk of relapse, and severe inflammation at local lesions." | ( Cai, J; Chen, H; Chi, J; Du, M; Feng, D; Li, F; Lin, L; Lu, C; Luo, R; Pan, X; Quan, G; Wang, H; Wang, L; Wu, C, 2022) |
| "Combating bacterial infections is one of the most important applications of nanomedicine." | ( Li, F; Ling, D; Wei, M; Wu, H; Zheng, Y, 2022) |
| "Pathogenic bacterial infections are the second highest cause of death worldwide and bring severe challenges to public healthcare." | ( Liu, J; Qin, S; Shi, J; Wang, J; Wei, Y; Wu, S; Zhang, K; Zhang, Z; Zhou, R, 2022) |
| "Bacterial infection is the leading cause of many serious inflammation diseases threatening human health." | ( Liu, B; Mao, D; Wu, W; Yang, P; Zhou, Y, 2022) |
| "Bacterial infection is a major complication associated with bioimplant materials, including titanium (Ti) based orthopedic joints and dental implants." | ( Arthanari, S; Bose, S; Chun, BS; Kang, HW; Lee, H; Surendhiran, D; Tran, VN, 2022) |
| "Bacterial infection is a major cause of mortality in patients with cirrhosis." | ( Ahmed, N; Balakrishnan, I; Bordea, E; Chau, M; China, L; Corless, L; Crocombe, D; Danquah, V; Dehbi, HM; Dillon, JF; Forrest, EH; Freemantle, N; Gear, DP; Hollywood, C; Hunter, R; Jeyapalan, T; Kallis, Y; McPherson, S; Munteanu, I; O'Brien, A; Portal, J; Richardson, P; Ryder, SD; Virk, A; Wright, G, 2022) |
| "Bacterial infection is common in acute cholecystitis (AC)." | ( Byun, Y; Choi, YJ; Jang, JY; Jin, SH; Kang, JS; Lee, HW; Lee, JM; Lim, CS; Yoon, KC, 2023) |
| "Bacterial infections are common during induction therapy in children and adolescents with acute leukaemia and may cause infection-related mortality." | ( Cheng, G; Diao, S; Jia, Z; Lu, X; Luo, J; Xin, L; Yang, M; Zeng, L; Zhang, L, 2023) |
| "Plant bacterial diseases are an intractable problem due to the fact that phytopathogens have acquired strong resistances for traditional pesticides, resulting in restricting the quality and yield of agricultural products around the world." | ( Chen, AQ; Ding, YG; Liu, LW; Liu, ST; Long, ZQ; Xie, J; Yang, S; Zhou, X, 2023) |
| "Bacterial infections are one of the leading causes of death worldwide." | ( Bondar, D; Bondarenko, O; Kahru, A; Karpichev, Y; Kubo, AL; Vasiliev, G; Vija, H, 2023) |
| "Bacterial infection is one of the most critical obstacles in wound healing, and severe bacterial infections can lead to inflammatory conditions and delay the healing process." | ( Cai, R; Guo, Y; Hu, L; Jiang, M; Li, S; Li, W; Tao, G; Wu, Z; Xie, X; Yuan, L; Zhang, Y; Zhao, J, 2023) |
| "Although bacterial infections are frequent during pregnancy, the prescription of antibiotics to pregnant women represents a challenge for physicians, driven by the benefit-risk balance." | ( Dray-Spira, R; Drouin, J; Duval, X; Miranda, S; Sibiude, J; Tran, A; Tubiana, S; Weill, A; Zureik, M, 2023) |
| Excerpt | Reference |
|---|
| "28 patients suffering from a variety of bacterial infections have been treated with cefuroxime." | ( Ball, AP; Brookes, GR; Farrell, ID; Geddes, AM; Gould, I, 1979) |
| "Forty-four patients with serious bacterial infections were treated with cefamandole in a dose 1--2 g every four to six hours." | ( Goldberger, MJ; Neu, HC; Parry, MF, 1978) |
| "However, the reduction in mortality from bacterial infection resulting from such an aggressive approach may be offset by a higher mortality from invasive fungal infection, especially in patients with prior fungal colonization and undergoing prolonged conditioning therapy." | ( Gale, RP; Meyer, DV; Winston, DJ; Young, LS, 1979) |
| "Ninety-three cases of proven bacterial infection occurring in general practice were treated with an amoxycillin/flucloxacillin combination." | ( Kritzinger, NA, 1979) |
| "Thirty-eight patients with severe mixed bacterial infections were treated with clindamycin and gentamicin." | ( Fass, RJ, 1977) |
| "Only one episode of bacterial infection was observed among 16 patients with SLE whose sera yielded normal amounts of chemotactic activity after treatment with zymosan." | ( Andron, RI; Goldstein, IM; Perez, HD, 1979) |
| "In acute bacterial infection, the 176 patients who had not received any antibacterial therapy prior to testing had a significantly higher mean NBT score and proportion (77." | ( Hellum, KB, 1977) |
| "Cefotaxime has been used to treat serious bacterial infections in children since 1982." | ( Darville, T; Enderlin, G; Jacobs, RF; Parks, JA, 1992) |
| "Cutaneous bacterial infections can be treated by a variety of modalities, although systemic antimicrobial agents usually provide the most efficacious and efficient means for treatment." | ( Parish, LC; Witkowski, JA, 1991) |
| "Ten children with 12 bacterial infections were treated with 9 mg/kg/day of CFDN fine granule." | ( Chiba, S; Nakata, S, 1990) |
| "The treatment of bacterial infections in neutropenic cancer patients presents a serious challenge to physicians." | ( Bodey, GP; Elting, L; Rolston, KV, 1990) |
| "Whipple's disease is a systemic bacterial infection that once was uniformly fatal and now is treatable with several different antibiotics in most cases." | ( Feldman, M, 1986) |
| "In addition, combined treatments of bacterial infections should allow for a reduction in dosages of antibiotics while at the same time, achieving increased efficacy." | ( Bizzini, B; Fattal-German, M, 1989) |
| "In addition, for the treatment of bacterial infections, diagnosed or suspected, or for the prophylaxis of bacterial infections, the drug was administered to a total of 27 neonates, premature babies and infants, with ages of 0 day to 3 months." | ( Fujimoto, T; Kawakami, A; Koga, T; Kuda, N; Motohiro, T; Nishiyama, T; Sakata, Y; Shimada, Y; Tanaka, K; Tomita, S, 1989) |
| "42 patients with bacterial infections caused by resistant to other available in this country antibiotics, immunocompromised patients and patients in severe life-threatening conditions were treated with ciprofloxacin (Ciprobay--Bayer) in tablets." | ( Belovezhdov, N; Monova, D, 1989) |
| "One hundred and thirteen patients were treated for bacterial infections with IPM/CS and 32 patients were treated prophylactically." | ( Fujii, R; Fujita, K; Hashira, S; Inyaku, F; Maruyama, S; Nakazawa, S; Sakata, H; Sato, H; Tajima, T; Yoshioka, H, 1989) |
| "To prevent bacterial infections in the neutropenic post-transplant period, norfloxacin 400mg twice daily was administered as oral prophylaxis to 44 marrow recipients isolated in laminar airflow rooms (LAFRs)." | ( Aversa, F; Bucaneve, G; Del Favero, A; Felicini, R; Greco, M; Martelli, MF; Menichetti, F; Moretti, MV; Pasquarella, C, 1989) |
| "Fifty-three patients with bacterial infections were treated with 8." | ( Abe, T; Arimasu, O; Kobayashi, M; Meguro, H; Shiraishi, H; Tajima, T, 1989) |
| "Treatment has been successful in 78% bacterial infections." | ( Bergerat, JP; Duclos, B; Dufour, P; Herbrecht, R; Lang, JM; Langs, JC; Oberling, F, 1988) |
| "Definite bacterial infections were identified in 67 patients; of the evaluable patients with a definite infection 27 of 29 who received ceftriaxone and 21 of 31 who were treated with the combination were cured (p = 0." | ( Hoepelman, IM; Rozenberg-Arska, M; Verhoef, J, 1988) |
| "The principal bacterial diseases of cultured rainbow trout (Salmo gairdneri) and channel catfish (Ictalurus punctatus), and the antibacterials used in their treatment are briefly reviewed." | ( Bullock, GL; Herman, RL, 1986) |
| "Twenty-six patients with bacterial infections were treated with FMOX." | ( Arimasu, O; Fujii, R; Kobayashi, M; Mashiko, J; Meguro, H; Nagao, Y; Okamoto, Y; Shiraishi, H; Sugamata, K, 1987) |
| "Four patients with bacterial infections were treated with MK-0787/MK-0791." | ( Fujimoto, H; Ikeda, K; Shirakawa, K; Taguchi, S; Yamamoto, K, 1986) |
| "Thirty cases of bacterial infections were treated with MK-0787/MK-0791 at a daily dose of 40 to 222 mg/kg for 2." | ( Arimasu, O; Fujii, R; Izumi, K; Kobayashi, M; Meguro, H; Shiraishi, H, 1986) |
| "Aerobic gram negative bacterial infections occur commonly in patients with acute leukemia undergoing intensive chemotherapy-induced bone marrow aplasia, and often arise from the gastrointestinal (GI) tract." | ( Bamberger, BJ; Bartlett, JG; Burke, PJ; Hendricksen, C; Karp, JE; Laughon, B; Merz, WG; Redden, T; Saral, R, 1986) |
| "Twenty-two cases of bacterial infections including pneumonia, lung abscess, sepsis, urinary tract infection and soft tissue infections were treated with CZON." | ( Arimasu, O; Fuji, R; Kobayashi, M; Mashiko, J; Meguro, H; Shiraishi, H, 1987) |
| "Seven patients were treated for bacterial infections with imipenem/cilastatin." | ( Breddin, HK; Henkel-Bussmann, M; Shah, PM; Ziemen, M, 1986) |
| "Imipenem/cilastatin was used for the treatment of 594 bacterial infections in 545 patients at a dosage of 1." | ( Shah, PM, 1986) |
| "Twenty-one pediatric patients with bacterial infections (10, tonsillitis; 4, pharyngitis; and 7, urinary tract infections) were treated with CFIX at doses of 1." | ( Hakamada, S; Hayakawa, F; Kuno, K; Miyachi, Y; Nakashima, S; Nakashima, T, 1986) |
| "We treated 15 patients with 16 proven bacterial infections with imipenem-cilistatin." | ( Bremner, DA; Downey, D; Ellis-Pegler, RB, 1985) |
| "This treatment reduces the incidence of bacterial infection in abnormal navels to zero." | ( Al-Nakhli, HM; Barbour, EK; Hinners, SW; Nabbut, NH, 1985) |
| "12 patients with acute bacterial infections were treated with ceftriaxone, 1." | ( Nilsson-Ehle, I; Nord, CE; Ursing, B, 1985) |
| "Thus a marked advancement in the treatment of bacterial infections is to be expected by this new intravenously tolerable immunoglobulin preparation." | ( Dichtelmüller, H; Schedel, I; Stephan, W, 1985) |
| "MDP still enhanced resistance to bacterial infections in animals with a poor immune status, like newborns or adult mice under immunosuppressive treatment." | ( Chedid, L; Parant, M, 1985) |
| "AZT was administered to 10 patients with bacterial infections with 100% clinical efficacy and 62." | ( Akita, H; Ishizuka, Y; Iwata, S; Saito, N; Sato, Y; Sunakawa, K, 1985) |
| "Seventy-seven patients with acute bacterial infections were treated with ceftriaxone (1 gm administered intravenously every 12 hours)." | ( File, TM; Salstrom, SJ; Tan, JS, 1984) |
| "Of 60 patients who were suffering from bacterial infections, 30 were treated with mezlocillin and 30 with carbenicillin in a randomized study." | ( Stepka, K; Tkacz, B, 1982) |
| "In 93 hospitalized patients, 111 bacterial infections were treated with moxalactam." | ( Becker, TM; Freimer, EH; Raeder, R; Ribner, BS, 1983) |
| "Systemic bacterial infections due to Escherichia coli MB 2884, Proteus mirabilis MB 3125 and Klebsiella pneumoniae MB 4005 were well controlled by treatment with norfloxacin both in normal and streptozotocin-induced diabetic mice." | ( Abruzzo, GK; Fromtling, RA; Gadebusch, HH, 1984) |
| "All but two patients of bacterial infections were cured after the CTM therapy, and the rate of efficacy was 87." | ( Fujii, R; Mashiko, J; Matsueda, Y; Meguro, H; Ozawa, S, 1981) |
| "Eighteen children with the following bacterial infections were treated with ceftizoxime; respiratory tract infection (13), acute otitis media (1), acute intervertebral chondritis and tonsillitis (1), chronic cystitis (1), subcutaneous abscess (1) and chronic bacteremia (1)." | ( Matsuda, H; Yoshida, T, 1982) |
| "Of the 20 confirmed bacterial infections, 19 were cured by CMX therapy (effective rate, 95%)." | ( Fujii, R; Hiraiwa, M; Kim, B; Meguro, H; Ozawa, S; Togo, T, 1982) |
| "In four patients with chronic bacterial infections who had low levels of neutrophil MPO activity, treatment with cefaclor led to a significant increase in the MPO levels to within the normal range." | ( Gormley, IP; Grant, M; Harkness, RA; Kowolik, MJ; Raeburn, JA; Sutherland, R, 1983) |
| "Of the 25 confirmed bacterial infections, 23 were cured by the CAZ therapy (efficacy rate, 92%)." | ( Arimasu, O; Fujii, R; Kim, B; Mashiko, J; Meguro, H; Ohnari, S; Sakamoto, M; Tagaya, M, 1984) |
| "Although the incidence of bacterial infections in the two groups was not statistically significantly different, almost twice as many bacterial infections were observed in the group that received the short course of empirical therapy." | ( Goldman, AI; Kersey, J; McGlave, P; Peterson, PK; Ramsay, NK; Rhame, F, 1984) |
| "The drug was administered to 21 cases of bacterial infections; respiratory tract infection (17), lymphadenitis (1), urinary tract infection (1), enterocolitis (1) and purulent meningitis (1)." | ( Furukawa, S; Hirao, F; Okada, T, 1980) |
| "Seventeen children wih the following bacterial infections were treated with CPZ; pneumonia (7), bronchitis (6), tonsillitis (1), sepsis (2) and purulent meningitis (1)." | ( Kagata, N; Matsuda, H; Niino, S; Yoshida, T, 1980) |
| "Other bacterial infections were treated with 55 to 200 mg/kg/day." | ( Akita, H; Hara, N; Hirose, M; Hotta, M; Ichihashi, Y; Morikawa, Y; Nanri, S; Sunakawa, K; Tojo, M; Yamashita, N, 1981) |
| "All the patients of bacterial infections were cured after the 6059-S therapy." | ( Arimasu, O; Fujii, R; Hiraiwa, M; Mashiko, J; Matsueda, Y; Meguro, H; Ozawa, S; Tohgo, T, 1981) |
| "Seventy infants with suspected bacterial infection in the first 48 hours of life were treated either with piperacillin and flucloxacillin or with penicillin and gentamicin." | ( Darrell, J; Placzek, M; Sahathevan, M; Want, S; Whitelaw, A, 1983) |
| "Fifteen children with acute bacterial infections, including pneumonia (8), pharyngitis (2), cervical lymphadenitis (1), perforative peritonitis (1), gastroenteritis (1) and urinary tract infection (2), were treated with cefotetan." | ( Fujita, K; Maruyama, S; Sakata, H; Sanae, N; Yoshioka, H, 1983) |
| "Forty-four patients with severe systemic bacterial infection were treated with azlocillin (20) or gentamicin (24)." | ( Loza, L; Sabbaj, J; Torres, M, 1983) |
| "Forty-three bacterial infections of 36 patients were treated; most of them were critically or seriously ill at the start of treatment." | ( Arr, M; Graber, H; Ludwig, E; Magyar, T, 1983) |
| "Of 36 patients with proven bacterial infection, 72% responded to treatment with complete resolution or improvement." | ( Geisler, C; Hansen, MM; Mortensen, N; Traun-Pedersen, P, 1980) |
| "The drug was administered to 19 cases of bacterial infections: acute tonsillitis (6), acute bronchitis (6), scarlet fever (2), acute pyelonephritis (4) and acute cystitis (1)." | ( Furukawa, S; Hirao, F; Okada, T, 1981) |
| "All the 10 patients of bacterial infections were cured after the CFX therapy." | ( Fujii, R; Hashimoto, G; Mashiko, J; Matsueda, Y; Meguro, H; Ohnari, S, 1981) |
| "4) Thirty patients with the following bacterial infections were treated with cefoxitin, i." | ( Haruta, T; Hayashi, R; Kasei, M; Kikawa, Y; Kobayashi, Y; Kuroki, S; Morikawa, Y; Murakami, M; Ookura, K; Tomizawa, T, 1981) |
| "Increased understanding of bacterial infections of the pelvis has led to the frequent administration of double and triple antimicrobial chemotherapy for polymicrobial infections in hospitalized patients." | ( Gall, SA; Hill, GB, 1980) |
| "In uncomplicated bacterial infections, both G-CSF and IL-6 were increased on day 0, and decreased rapidly after initiation of antibacterial therapy and before the patients became afebrile." | ( Elfman, L; Pauksen, K; Ulfgren, AK; Venge, P, 1994) |
| "To determine whether bacterial infection is an important component in the pathogenesis of an exacerbation, the effects of antimicrobial treatment must be studied." | ( Groenier, KH; Koëter, GH; Meyboom-de Jong, B; Sachs, AP; Schiphuis, J; van der Waaij, D, 1995) |
| "Thirty patients with severe bacterial infections were treated with 50 mg of cefodizime per kg of body weight once daily or 50 mg of ceftriaxone per kg once daily for 10 +/- 3 days." | ( Graninger, W; Hasenhündl, M; Parschalk, B; Wenisch, C; Wiesinger, E, 1995) |
| "122 patients with bacterial infections of respiratory tract, ear, nose, and throat, urinary tract and skin and soft tissue were treated with cefpodoxime proxetil." | ( Hou, J; Kao, L; Li, JT, 1994) |
| "In a word, both drugs are effective in treating bacterial infections of digestive system, urinary system and respiratory tract." | ( Jiang, SC; Miao, JZ; Wang, XF, 1994) |
| "Severe bacterial infection was diagnosed when the patient's condition has justified an intravenous antibiotherapy." | ( Broyer, M; Cochat, P; David, L; Gagnadoux, MF; Liponski, I; Niaudet, P; Parchoux, B, 1995) |
| "Nine pediatric patients with bacterial infections (5 cases of tonsillitis, 3 cases of impetigo and 1 case of UTI) were treated with S-1108, and the efficacy and the safety were evaluated." | ( Aoki, S; Nishimura, T; Sugita, K; Takagi, M, 1993) |
| "Patients treated included those with bacterial infections of the lower respiratory tract, urinary tract and skin and soft tissues, abdominal, obstetric and gynaecological infections, meningitis, febrile episodes in neutropenic patients and paediatric patients with infections." | ( Faulkner, KL; Lesky, W; Newell, PA; Norrby, SR, 1995) |
| "The recognition that bacterial infections induce signal transduction responses in infected epithelial cells also provides new avenues to consider as novel forms of therapy." | ( Cohen, MB; Petric, M; Sherman, PM, 1996) |
| "Fifteen patients with severe bacterial infection (12 with pneumonia) that developed in the resuscitation unit were subjected to the empirical monotherapy with piperacillin/tazobactam (P/T) or tazocin under an open randomized controlled experiment." | ( Dvoretskiĭ, LI; Eremina, LV; Iakovlev, SV; Kaĭnov, MS; Koroleva, TA; Orlova, EA; Romanovskiĭ, IuIa; Shakhova, TV; Zhulin, SL, 1997) |
| "The incidence of proven bacterial infection in the ciprofloxacin-treated group was significantly lower than that of placebo group (10% vs 45%, p < 0." | ( Chang, FY; Hou, MC; Hsieh, WJ; Hwang, SJ; Lee, FY; Lee, SD; Lin, HC, 1998) |
| "PCT values are higher in invasive bacterial infections, but the cutoff value of 1 microg/l indicates the severity of the disease in localized bacterial infection and helps to decide antibiotic treatment in emergency room." | ( Bohuon, C; Coste, J; Gendrel, D; Guérin, S; Lacombe, C; Lefèvre, H; Lorrot, M; Moulin, F; Palmer, P; Ravilly, S; Raymond, J; Royer, C, 1999) |
| "High fibrinogen levels were related to bacterial infections in 67% of placebo-treated mice and predicted mortality, whereas the majority of the thrombopoietin-treated mice did not show high fibrinogen levels and endotoxin was not detectable in plasma." | ( Gaugler, MH; Gourmelon, P; Mouthon, MA; Van der Meeren, A; Vandamme, M; Wagemaker, G, 2001) |
| "The therapy of bacterial infections is currently a difficult problem of the contemporary medicine, mainly due to the increasing spread of resistance to conventional antibiotics and to the appearance of multi-resistant bacterial strains." | ( Igaz, P, 2001) |
| "The global challenge of optimally treating bacterial infections is continuously evolving." | ( Amsden, GW; Duran, JM, 2000) |
| "Of those, a bacterial infection, with or without concomitant viral infection, was disclosed in 80% and 94% in the 4-day and 7-day treatment groups, respectively; pneumococcus being the commonest agent." | ( Kallio, MJ; Peltola, H; Vuori-Holopainen, E, 2001) |
| "The diagnosis of deep seated bacterial infections, such as intra-abdominal abscesses, endocarditis, and osteomyelitis, can be difficult and delayed, thereby compromising effective treatment." | ( Amaral, H; Bhatnagar, A; Britton, KE; Das, SS; Katamihardja, AH; Malamitsi, J; Moustafa, HM; Padhy, AK; Solanki, KK; Soroa, VE; Sundram, FX; Wareham, DW, 2002) |
| "Empirical treatment of early bacterial infection should include vancomycin or teicoplanin." | ( Cuervas-Mons, V; Dámaso, D; Losada, I; Millán, I, 2002) |
| "The incidence of bacterial infections was significantly lower in the treatment group than the control group (p < 0." | ( Choi, KW; Choi, MS; Hong, SN; Kim, BJ; Kim, JJ; Koh, KC; Lee, CY; Lee, JH; Lee, SY; Paik, SW; Rhee, JC; Rhee, PL; Ryu, MK, 2002) |
| "We evaluated bacterial infections (BIs) in patients with multiple myeloma (MM) treated with two different schedules of vincristine-adriamycin-dexamethasone (VAD)." | ( Barbarano, L; Cesana, C; Ferrando, P; Klersy, C; Miqueleiz, S; Morra, E; Nosari, AM; Rossi, V; Valentini, M, 2003) |
| "prevention of overwhelming bacterial infection, present indications and controversies regarding blood transfusion, prevention of stroke, acute chest syndrome, hydroxyurea therapy--probably the best disease modifying agent at the moment, stem cell transplantation--a cure and certain promising experimental therapies including gene therapy have been discussed in this review." | ( Agarwal, MB, 2003) |
| "Because the efficacy of TMP-SMZ for treatment of bacterial infections is limited, it is sometimes poorly tolerated, and there is risk of emergence of drug-resistant strains associated with widespread use, we evaluated a regimen that included atovaquone and azithromycin." | ( Dankner, WM; Flores, MA; Huang, S; Hughes, WT; Kline, MW; Paul, ME; Wei, LJ; Yogev, R, 2005) |
| "Due to a high number of bacterial infections antibiotics administration has been indicated in these patients." | ( Dastych, M; Díte, P; Husová, L; Juránková, J; Lata, J; Príbramská, V; Senkyrík, M, 2004) |
| "There have been reported cases with bacterial infection resulting pseudo Tolosa-Hunt syndrome, which have good response to antibiotics treatment with excellent prognosis." | ( Fujiki, F; Saitoh, N; Tsuboi, Y; Yamada, T, 2005) |
| "However, bacterial infections are important causes of high fever in patients receiving myelosuppressive chemotherapy, and such fevers persist despite the use of COX inhibitors." | ( Dascombe, MJ; Maldonado, R; Miñano, FJ; Tavares, E, 2006) |
| "Identification of bacterial infections is crucial if treatment is to be initiated early and antibiotics used rationally." | ( Bernard, M; Haroche, J; Hausfater, P; Juillien, G; Madonna-Py, B; Riou, B, 2007) |
| "To evaluate the risk of bacterial infection and neutropenia in patients with CHC treated with peginterferon-alpha/ribavirin." | ( Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, JF; Lin, ZY; Wang, LY; Yang, JF; Yu, ML, 2009) |
| "There was a higher incidence of bacterial infections in treated patients vs controls, particularly in Child-Pugh B-C individuals (17 vs 3 episodes) (log-rank=0." | ( Carrión, JA; Crespo, G; Forns, X; García-Valdecasas, JC; Martínez-Bauer, E; Navasa, M; Pérez-del-Pulgar, S; Ramírez, S, 2009) |
| "Thirty-nine foals suffering from severe bacterial infections (such as pneumonia, gastro-enteritis, arthritis, omphalitis, or wound infections) or acute septicaemia were treated twice daily with the test product (1 mg cefquinome/kg body weight) intravenously for three days and then intramuscularly for three to 11 days." | ( Heckeroth, A; Leendertse, I; Rohdich, N; Thomas, E; Wilhelm, C; Zschiesche, E, 2009) |
| "Anaerobic bacterial infections caused by Bacteroides species, fusobacteria, and clostridia respond favorably to metronidazole therapy." | ( Edlund, C; Löfmark, S; Nord, CE, 2010) |
| "A procalcitonin-guided strategy to treat suspected bacterial infections in non-surgical patients in intensive care units could reduce antibiotic exposure and selective pressure with no apparent adverse outcomes." | ( Alvarez, A; Bernard, M; Bouadma, L; Brun-Buisson, C; Chastre, J; Cracco, C; Dehoux, M; Lasocki, S; Luyt, CE; Pasquet, B; Régnier, B; Schortgen, F; Schwebel, C; Tubach, F; Veber, B; Wolff, M, 2010) |
| "Accurate identification of bacterial infections in patients presenting at the emergency department is crucial for early and rational antibiotic treatment." | ( Bernard, M; Brochet, C; Charles, V; Freund, Y; Hausfater, P, 2010) |
| "Levofloxacin reduced the bacterial infections and delays the onset of fever in chemotherapy-induced neutropenia especially in short duration (< 7 days)." | ( Khan, MA; Rahman, MM, 2009) |
| "Early differentiation between bacterial infections and disease flares in autoimmune disease patients is important due to different treatments." | ( Joo, K; Kwon, SR; Lim, MJ; Park, W; Yoon, J, 2011) |
| "The continued ability to treat bacterial infections requires effective antibiotics." | ( Fujimori, DG; McCusker, KP, 2012) |
| "The 1st Global Forum on Bacterial Infections: Balancing Treatment Access and Antibiotic Resistance was organized by the Center for Disease Dynamics, Economics and Policy and the Public Health Foundation of India for researchers, policymakers, clinicians and public health program managers dealing with the problems of bacterial infection and antibiotic resistance in low- and middle-income countries." | ( Vlieghe, E, 2012) |
| "After 3 patients died from bacterial infections, treatment with vancomycin, levofloxacin, and voriconazole prophylaxis resulted in no further infectious mortality in the last 6 patients." | ( Bostrom, BC; Eckroth, E; Gaynon, PS; Malvar, J; Messinger, YH; Sposto, R; van der Giessen, J, 2012) |
| "Early recognition of serious bacterial infection (SBI) in children is essential for better treatment outcome." | ( Bosnjak, N; Culic, VC; Jeroncic, A; Markic, J; Markotic, A; Mestrovic, J; Polancec, D, 2013) |
| "A high number of tuberculosis and bacterial infections and a high case fatality rate from sepsis were found in this cohort, underlining the importance of microbiological diagnostics and targeted antimicrobial treatment in the management of fever." | ( Abrahamsen, SK; Eide, GE; Haugen, CN; Langeland, N; Mathai, D; Mørch, K; Rupali, P, 2013) |
| "Two canine models of clinical anaerobic bacterial infections were developed for the study of the clinical parameters associated with these infections and for evaluation of antimicrobial agents that might be useful in therapy." | ( Berg, JN; Buening, GM; Fales, WH; Scanlan, CM; Schmidt, DA; Wilson, JC, 1984) |
| "Carbapenems are an effective tool to treat complicated bacterial infections." | ( Allegaert, K; Pacifici, GM, 2014) |
| "Our data show that the development of bacterial infections during treatment with PegIFNa and ribavirin in patients with compensated CHC is not associated with reduction or the nadir of white cells or neutrophil counts." | ( Anagnostou, O; Andreadis, I; Deutsch, M; Kalafateli, M; Ketikoglou, I; Manolakopoulos, S; Mela, M; Papatheodoridis, G; Pectasides, D; Schini, M; Striki, A; Triantos, C, 2014) |
| "Determination of risk of severe bacterial infection complication in children with cancer is important to diminish the cost of hospitalization and therapy." | ( Arisoy, ES; Corapcioglu, F; Demirsoy, U; Karadogan, M; Karakurt, DG; Oncel, S, 2014) |
| "In the diagnosis and treatment of bacterial infections, three aspects must be considered: the appropriateness of antibacterial therapy, the initiation and evaluation of an effective initial therapy, and termination of the antimicrobial treatment." | ( Bodmann, KF, 2014) |
| "The treatment of bacterial infection is one of the most challenging tasks in the biomedical field." | ( Li, LL; Qi, GB; Wang, H; Xu, JH; Yu, F; Zhao, X, 2014) |
| "The diagnosis of bacterial infections in patients with solid tumours can be difficult as both the tumour and its treatment can cause symptoms and signs similar to those of infections." | ( Diness, LV; Larsen, FO; Maraldo, MV; Mellemgaard, A; Mortensen, CE, 2014) |
| "The impact of treated preoperative bacterial infections on the outcome of living-donor liver transplantation (LDLT) is not well defined." | ( Adachi, T; Carpenter, I; Eguchi, S; Hara, T; Hidaka, M; Kinoshita, A; Kitasato, A; Kuroki, T; Soyama, A; Takatsuki, M, 2014) |
| "The occurrence of a bacterial infection during anti-viral treatment was defined as the onset of local or systemic inflammation as a result of pathogenic bacteria." | ( Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Kajiwara, E; Kawano, A; Kotoh, K; Nakamuta, M; Nomura, H; Ogawa, E; Satoh, T; Shimoda, S; Takahashi, K; Tanabe, Y, 2015) |
| "The distribution of bacterial infection sites, type of bacteria, type of antibiotics, average period of hospitalization, and course of antibiotic treatment were compared between the two groups." | ( Lin, C; Luo, L; Shi, L; Situ, J; Wei, S; Yang, X; Zhang, J; Zhang, N, 2015) |
| "Under similar conditions of bacterial infection, antibiotic treatment of TCE-induced dermatitis based on the serum PCT level can significantly shorten the course of treatment and avoid the abuse of antibiotics." | ( Lin, C; Luo, L; Shi, L; Situ, J; Wei, S; Yang, X; Zhang, J; Zhang, N, 2015) |
| "Early identification of bacterial infection in patients with fever is important for prompt treatment." | ( L, X; Liu, Y; Qu, J; Wang, X, 2015) |
| "Rapid diagnosis of bacterial infections is crucial for adequate antibiotic treatment." | ( Angeletti, S; Cavalieri, D; Cortigiani, M; Costantino, S; Curcio, B; De Florio, L; Dicuonzo, G; Fioravanti, M; Fogolari, M; Spoto, S, 2015) |
| "The treatment of bacterial infections is challenging because of a decline in the current arsenal of useful antibiotics and the slow rate of new drug development." | ( Devereux, M; Howe, O; McCann, M; McCarron, P; Viganor, L, 2017) |
| "The risk of developing selected bacterial infections was significantly lower in patients treated with rifaximin (OR 0." | ( Bruno, R; Columpsi, P; Filice, G; Lombardi, A; Mariani, M; Marone, P; Patruno, SF; Sacchi, P; Scudeller, L; Vecchia, M; Zuccaro, V, 2017) |
| "Treatment of bacterial infections due to the fast emergence of drug-resistant bacteria is a significant challenge faced in modern medicine." | ( Chen, AY; He, M; Miron, RJ; Wang, YL; Zhang, YF; Zhao, YB, 2017) |
| "It is used to treat different types of bacterial infections including pneumonia, bone infections, abdominal infections, Skin and soft tissue infections, urinary tract infections." | ( Ayele, AA; Demssie, DG; Erku, DA; Gebresillassie, BM; Gebreyohannes, EA; Mersha, AG; Tegegn, HG, 2018) |
| "Vancomycin is commonly used to treat resistant bacterial infections in people." | ( Babyak, JM; DeStefano, IM; Rozanski, EA; Wayne, AS, 2019) |
| "Amoxicillin is widely used to treat bacterial infections in neonates." | ( Huang, X; Jacqz-Aigrain, E; Kou, C; Leroux, S; Qi, H; Qi, YJ; Shen, AD; Tang, BH; Wu, YE; Xu, HY; Zhao, W; Zheng, Y; Zhou, Y, 2019) |
| "The major challenge in bacterial infection in clinical settings is the development of antimicrobial materials in the treatment of drug-resistant bacteria." | ( Cai, S; Hua, D; Kuang, L; Qian, J; Yang, S, 2019) |
| "The current therapy for bacterial infections includes treatment with various drugs and antibiotics." | ( Md, AA; Saha, N; Yele, V, 2019) |
| "The trends in treating bacterial infections using adaptive biomaterials-based systems are flourishing and generate innumerous possibility to design novel antimicrobial therapeutics." | ( An, Y; Li, Y; Liu, Y; Shi, L; Su, L, 2019) |
| "The introduction of antibiotics to treat bacterial infections either by killing or blocking their growth has been accompanied by the studies of mechanism that allows the drugs to kill the bacteria or to stop their proliferation." | ( Mauro, P; Shan, L; Stefano, B; Wenling, Q, 2020) |
| "New strategies to prevent and treat bacterial infections by eradication of the biofilms are urgently needed." | ( Li, H; Mao, ZW; Tao, X; Xia, W; Xie, Y; Yang, L; Zhao, Z, 2021) |
| "To determine the prevalence of bacterial infections during cyclosporine therapy in dogs, 2 databases were searched and 14 articles reporting usable data were identified." | ( High, EJ; Olivry, T, 2020) |
| "Neonatal bacterial infections are a common cause of death, which can be managed well with inpatient treatment." | ( Aboubaker, S; Abraham, L; Bahl, R; Bayray, A; Fantaye, M; Godefay, H; Hailu, T; Leul, A; Mulugeta, A; Nisar, YB; Qazi, SA; Tekle, E; Terefe, W, 2021) |
| "The failure to treat everyday bacterial infections is a current threat as pathogens are finding new ways to thwart antibiotics through mechanisms of resistance and intracellular refuge, thus rendering current antibiotic strategies ineffective." | ( Chmielewski, J; Zeiders, SM, 2021) |
| "Meropenem is frequently used for the treatment of severe bacterial infections in critically ill patients." | ( Djebli, N; Khier, S; Larcher, R; Le Souder, C; O'Jeanson, A, 2021) |
| "Treatment of bacterial infections is challenging, mainly attributed to the rapidly evolving resistance mechanisms, creating an urgent demand to develop novel antibacterial agents." | ( Hu, G; Jiang, D; Liu, B, 2022) |
| "The treatment of pathogenic bacterial infection has long been the most serious threat to human life and attracted widespread attention." | ( Cai, H; Cao, H; Chu, J; Tian, J; Xia, L; Yue, T; Zhang, W, 2022) |
| "Despite the recent advancements in treating bacterial infections, antibiotic resistance (AR) is still an emerging issue." | ( Abdelmalek, F; Rofeal, M; Steinbüchel, A, 2022) |
| "Focal bacterial infections are often difficult to treat due to the rapid emergence of antibiotic-resistant bacteria, high risk of relapse, and severe inflammation at local lesions." | ( Cai, J; Chen, H; Chi, J; Du, M; Feng, D; Li, F; Lin, L; Lu, C; Luo, R; Pan, X; Quan, G; Wang, H; Wang, L; Wu, C, 2022) |
| "Neonates with serious bacterial infections should be treated with injectable antibiotics after hospitalization, which may not be feasible in many low resource settings." | ( Aboubaker, S; Bahl, R; Bose, C; Coppieters, Y; Ishoso, D; Kalonji, M; Kokolomami, J; Lokangaka, A; Nisar, YB; Otomba, J; Qazi, SA; Takoy, P; Tshefu, A, 2022) |
| "The treatment for epidermal bacterial infections has become a primary healthy concern, producing a significant therapeutic challenge." | ( Gao, Y; Liu, L; Ma, H; Ma, Q; Sun, W; Sun, Y; Wang, S; Zhao, W; Zhu, C, 2022) |
| "The ability to effectively detect bacterial infection in human tissues is important for the timely treatment of the infection." | ( Chen, ZH; Gan, HQ; Gong, T; He, XP; Hu, XL; James, TD; Luo, PF; Shu, FT; Wei, P; Xia, ZF; Yan, KC; Yang, XL; Zheng, YJ; Zhong, CJ, 2022) |
| "The spread of bacterial infections has become a severe concern for the treatment system because of the simultaneous drug resistance bacteria and SARS-CoV-2 hospitalized patients." | ( Babapoor, E; Dezfulian, M; Rahmati, M, 2022) |
| "Resistant bacterial infections have become more common in recent years, its treatment becomes a difficult problem." | ( Aslan, K; Bör, Ö; Bozan, G; Dinleyici, EÇ; Kiliç, Ö; Kiral, E, 2022) |
| "Antibiotics are commonly used to treat bacterial infections." | ( Carbonari, A; Jirillo, F; Lillo, E; Piccinno, M; Rizzo, A; Sciorsci, RL, 2023) |
| "Confirming bacterial infection at an early stage and distinguishing between sterile inflammation and bacterial infection is still highly needed for efficient treatment." | ( Deng, S; Li, L; Liu, M; Song, E; Song, Y; Zhu, X, 2023) |
| "Antibiotic beads are used to treat local bacterial infections by delivering high drug concentrations to infected tissue." | ( Ithisariyanont, B; Poapolathep, A; Poapolathep, S; Udomkusonsri, P, 2023) |